- Generic name
- Ondansetron
- Strength
- 4 mg
- Dosage form
- Tablet
- Manufactured by
- Rangs Pharmaceuticals Ltd.
Emitof 4 Tablet
About Emitof 4 Tablet
Emitof 4 is a tablet from Rangs Pharmaceuticals Ltd., with the generic name Ondansetron. It is an anti-emetic, meaning it works against vomiting rather than treating the underlying condition.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Emitof 4 Tablet?
Emitof 4 4 mg tablet is a medicine made by Rangs Pharmaceuticals Ltd. It is used in adults and children for prevention of nausea and vomiting caused by chemotherapy or radiotherapy, and for prevention and treatment of nausea and vomiting after surgery. It belongs to a group of medicines called anti-emetics, and its active ingredient is Ondansetron. The doctor decides the dose and course.
Uses of Emitof 4
It is an anti-emetic, meaning it works against vomiting rather than treating the underlying condition. It is not meant to be used for everyday stomach upset unless a doctor advises it. Emitof 4 4 mg tablet is used to prevent nausea and vomiting caused by initial and repeat courses of cancer chemotherapy. The doctor will decide if it is suitable and how it should be used.
How to use Emitof 4
Take Emitof 4 exactly as the doctor tells you. Swallow the tablet with water. Emitof 4 is taken by mouth. The doctor will decide the dose and course of Emitof 4 for you. Tell your doctor about all other medicines you take, because some medicines can affect how Ondansetron works in the body.
Side effects of Emitof 4
Common side effects of Emitof 4 may include headache, constipation, and diarrhea. Some people may have side effects after Emitof 4. Some people have reported a feeling of flushing or warmth, hiccups, and changes in liver enzymes. Tell your doctor if you have any side effect that worries you or does not go away. Tell your doctor or nurse if you feel unwell after the tablet.
Safety and precautions
It is not a medicine that speeds up stomach or bowel movement and should not replace other treatments your doctor advises. If you have had abdominal surgery, or have cancer-related nausea and vomiting, tell your doctor, as the medicine may hide other problems. Tell the doctor if you have reacted badly to other similar anti-sickness medicines, or if you have had stomach or bowel surgery, because the medicine can hide signs of a bowel problem. Your doctor will decide if it is right for you.
Frequently asked questions
Why is Emitof 4 prescribed?
It is an anti-emetic, meaning it works against vomiting rather than treating the underlying condition. It is not meant to be used for everyday stomach upset unless a doctor advises it.
How should I take Emitof 4?
Take Emitof 4 exactly as the doctor tells you. Swallow the tablet with water.
What are the side effects of Emitof 4?
Common side effects of Emitof 4 may include headache, constipation, and diarrhea. Some people may have side effects after Emitof 4.
Who should be careful with Emitof 4?
It is not a medicine that speeds up stomach or bowel movement and should not replace other treatments your doctor advises. If you have had abdominal surgery, or have cancer-related nausea and vomiting, tell your doctor, as the medicine may hide other problems.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.